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Abstract
The dicistrovirus Israeli Acute Paralysis Virus (IAPV) has been implicated in the worldwide decline of honey bees. Studies of
IAPV and many other bee viruses in pure culture are restricted by available isolates and permissive cell culture. Here we
show that coupling the IAPV major structural precursor protein ORF2 to its cognate 3C-like processing enzyme results in
processing of the precursor to the individual structural proteins in a number of insect cell lines following expression by a
recombinant baculovirus. The efficiency of expression is influenced by the level of IAPV 3C protein and moderation of its
activity is required for optimal expression. The mature IAPV structural proteins assembled into empty capsids that migrated
as particles on sucrose velocity gradients and showed typical dicistrovirus like morphology when examined by electron
microscopy. Monoclonal antibodies raised to recombinant capsids were configured into a diagnostic test specific for the
presence of IAPV. Recombinant capsids for each of the many bee viruses within the picornavirus family may provide virus
specific reagents for the on-going investigation of the causes of honeybee loss.
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Introduction
An annual loss of honey bee colonies has been reported across
the United States and more recently Europe, a proportion of
which has been termed Colony Collapse Disorder (CCD) [1]. The
consequential loss to agriculture as a result of reduced bee enabled
pollination has been widely reported [2]. Honey bee loss and CCD
may have multifactorial origins including loss of rural habitat,
pesticide use, mite infestation and pathogen load [3–5]. Patho-
genic bee viruses may play a role but as a number of common
viruses are found, Kakugo virus; Varroa Destructor Virus;
Sacbrood Virus; Deformed Wing Virus, Kashmir Bee Virus and
Israeli Acute Paralysis Virus [6–8], a definitive link between any
one infection and CCD has been difficult to establish. An early
metagenomic analysis of hives that suffered CCD identified Israel
Acute Paralysis Virus (IAPV) as a highly correlated risk factor [9]
although other viruses, notably Deformed Wing Virus, have since
been implicated. Infection is linked to Varroa mite infestation
[10,11]. While the precise causes of CCD remain unknown the
horizontal transfer of pathogenic viruses from mites to bees is a
possible factor in CCD with parallels in other cases of viruses
crossing the species barrier [12,13]. Direct evidence from areas of
emerging CCD occurrence [14] or from model studies of Varroa
stimulated virus transmission [15,16] lends support to such a
possibility. IAPV can be vectored by Varroa [17] and has recently
been shown to concentrate in the heads of bees and alter foraging
behaviour, plausibly leading to bee disorientation and loss [18].
Many of the known bee viruses belong to the Picornaviridae
and Dicistroviridae families, both of which are characterised by
icosahedral particles of a pseudo T=3 symmetry and have similar
protein coding and virus assembly pathways. In the environment
multiply infected hives are common [19–21] which, with virus
strain variation and limited permissive honey bee cell culture
[22,23], make studies on the pathogenic contribution attributable
to any single infectious virus difficult.
In contrast, the assembly of non-infectious picornavirus empty
capsids has been reported for several picornaviruses [24–27] and
we showed recently that the level of such capsids could be
improved by regulating the level of the 3C protease required for
capsid protein maturation [28,29]. Here we apply the same
expression strategy to IAPV to show that empty IAPV capsids can
be assembled in insect cells following expression using recombi-
nant baculoviruses. Capsids allowed the generation of monoclonal
antibodies (MAbs) whose epitopes were subsequently mapped.
Two non-competing MAbs were configured as a capture ELISA
assay that detected IAPV antigen in expressing cells. We suggest
that recombinant empty capsid synthesis may be a generally useful
tool for the generation of specific reagents for fundamental and
applied studies of many honeybee viruses.
Results
First reported in 2007 [30], IAPV has since been found
worldwide with at least 2 strains co-circulating in the United States
and Canada [31]. IAPV has been independently isolated in France
in a screen of apiary overwintering losses [32] and more recently in
Argentina [33], Japan [34] China [20] and Spain [21,35]. Despite
this, there are relatively few specific regents for the non-nucleic
acid based detection of IAPV particles. In order to allow detection
of IAPV expression in a heterologous expression system we first
generated a specific antibody for IAPV following a high
throughput screen for stable expression of the predicted individual
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mature structural proteins of IAPV as His-tagged proteins in E.coli
[36]. A synthetic IAPV ORF2 (NC_009025, codon optimised for
Spodoptera cells) was used as template for the amplification of
fragments encoding VP2+VP4, VP2, VP3 and VP1 with junctions
based on an alignment of IAPV ORF2 with the known endpoints
in Solenopsis invicta virus 1 where they have been formally
mapped [37] (Figure 1A and 1B). Of the fragments screened, only
that encoding VP2 gave rise to detectable amounts of protein
(Figure 1C). Recombinant VP2 was purified by immobilised metal
chromatography (Figure 1C) and the purified protein used to
generate a high titre polyvalent serum in rabbits which did not
cross react with insect cells (not shown).
To assess expression of IAPV ORF2 as an intact polyprotein
and following cleavage into mature virus structural proteins we
assembled baculovirus transfer vectors with the sequence encoding
ORF2 as a sole open reading frame and, in other variants
appended at the ORF2 carboxyl–terminus to the sequence
encoding the putative IAPV 3C like protease responsible for
ORF2 maturation, normally part of the ORF1 polyprotein. The
3C protease activity in many picornaviruses is associated with host
cell shutdown through the cleavage of cellular targets e.g. [38] so
we attenuated the level of 3C expression by the introduction of a
ribosomal frameshift sequence between the sequence encoding
ORF2 and that encoding IAPV 3C as described recently for Foot
and Mouth Disease Virus [28]. In an additional modification we
reduced the frameshift rate further through shortening of the
‘‘slippery sequence’’ where ribosomal slippage occurs from six to
five uracils which reduces the frequency of the -1 frameshifting
event [39,40]. These constructions (Figure 2A) are predicted to
reduce the level of 3C enzyme while maintaining the same level of
ORF2 translation. Following sequence verification recombinant
baculoviruses were produced as described [41] and high titre
stocks were used to infect Spodoptera frugiperda (Sf9) cells.
Infected cells were harvested at two days post infection and total
cell extracts assessed by SDS-PAGE and western blot for the
presence of VP2 related antigen, by probing with the generated
rabbit anti-VP2 serum, and for level of infection by probing for the
baculovirus major surface glycoprotein gp64. Expression of ORF2
Figure 1. The IAPV genome and origin of sequences used for IAPV fragment expression. A. Genome structure of IAPV dicistrovirus with
the two open reading frames and their constituent mature proteins shown. IRES – internal ribosome entry site, IGR – intergenic region. B. The
fragments targeted for expression in E.coli and their encoded products. The precise endpoints used were: VP2, VTHRMQC; VP2-4, VTHRFGW; VP3,
SKPRELQ; VP1, INIRISR. Expression screening for the proteins predicted from the fragments shown in B. C- left. Western blot with anti-His antibody.
C-right. Purified VP2 used for the generation of a rabbit serum. Numbers to the left of the blot are protein molecular mass markers and are in
kilodaltons.
doi:10.1371/journal.pone.0105943.g001
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alone resulted in very intense staining of a band at ,100 kDa with
a considerable number of smaller products, the result of non-
specific proteolysis within the expressing Sf9 cells (Figure 2B track
1). When ORF2 was coupled in frame to the 3C protease the band
at ,100 kDa was wholly processed to a single species of ,39 kDa
consistent with the expected molecular weight of the mature VP2
product (Figure 2B track 3). However the level of signal was lower
than ORF2 alone. When the 3C protease was coupled to the C
terminus of ORF2 in the 21 frame via a ribosomal frameshift site
precursor processing to VP2 was improved when compared to that
observed following direct fusion (Figure 2B track 2). When the
ribosomal frameshift frequency was reduced by use of a 5 U
slippage sequence the level of the VP2 signal approached that of
the unprocessed precursor (Figure 2B track 4). The level of
baculovirus infection by these viruses was broadly similar as
defined by the level of the baculovirus encoded gp64 protein
(Figure 2B middle panel). Thus IAPV 3C processes the ORF2
precursor following expression in Sf9 cells and the level of cleavage
observed is affected by the ratio of enzyme to substrate (Figure 2B
lower panel).
To confirm IAPV protein expression as a result of Sf9 cell
infection by recombinant baculoviruses, infected cells at two days
post infection were fixed and permeablised and incubated with
anti VP2 serum followed by a fluorescent anti-rabbit conjugate
and visualised by fluorescence microscopy. Expression of ORF2
alone gave rise to bright fluorescence distributed throughout the
cytoplasm (Figure 3A). The signal from the optimised (frameshift
with 5Ts) recombinant, ORF2-5T-3C, was somewhat reduced but
also distributed within the expressing cell although occasional
punctate staining was apparent (Figure 3B). These data suggest
that processing of the IAPV structural precursor protein may be
associated with some redistribution of recombinant antigen within
the expressing cell, plausibly as a result of assembly of the cleaved
structural proteins into discistrovirus like capsids. To confirm that
capsid assembly was occurring in this heterologous expression
system, cells infected with the optimised recombinant baculovirus
expressing ORF2-5T-3C were lysed at two days post infection and
the cytoplasmic contents fractionated on sucrose velocity gradi-
ents. VP2 reactive antigen was found in the middle fractions,
typically around 40% sucrose, reflecting a higher molecular weight
than would be expected for VP2 alone (Figure 4A). When peak
fractions from the gradient were absorbed onto carbon coated
formvar grids and analysed by transmission electron microscopy,
particles with the shape and dimensions typical of assembled
dicistrovirus capsids were observed in addition to baculovirus
nucleocapsids which co-sedimented in the same sucrose fractions
(Figure 4B). Many recombinant dicistrovirus capsids had taken up
stain showing them to be hollow as expected of assembly in the
absence of a packageable genome (Figure 4B arrowed). Control
extracts processed from baculovirus only infected cells showed no
such particles, only baculovirus nucleocapsids (not shown). Some
particles appeared damaged and other material of regular size
Figure 2. Design and test of baculovirus expression cassettes. A. Cartoon representations of the various genetic constructs used to assess
IAPV antigen expression in infected Sf9 cells. The sequences used are identified. FS- the HIV-1 frameshift site, the polypyrimidine tract of which is
indicated. 3C-pro – the IAPV 3C like protease. B. Western blots of Sf9 cells infected for 2 days with recombinant baculoviruses constructed with the
cassettes shown in A. In B the upper panel was blotted with rabbit anti-VP2 serum, the middle panel with anti-gp64 and the lower panel is the
relative VP2:gp64 level. Numbers to the left of the blots are protein molecular mass markers (M) and are in kilodaltons. The expected position of the
blotted antigens is indicated.
doi:10.1371/journal.pone.0105943.g002
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would be consistent with disassembled capsids. A high level of
disassembled capsid material has also been observed in EM grids
of Triatoma virus [42]. Well defined particles did not show the
obvious angular profile typical of picornavirus icosahedra reflect-
ing the fact that dicistrovirus structures, while possessing icosahe-
dral symmetry, are generally more spherical, shown classically for
cricket paralysis virus [43] and more recently for Infectious
flacherie virus [44] although projections around the 5 fold axes
were observed in the recently solved Triatoma dicistrovirus
structure [45].
The predominant diagnostic test for IAPV presence is nucleic
acid amplification using specific primers e.g. [46], a very sensitive
but technologically demanding assay. To enable the development
of an antibody based diagnostic assay as an alternative tool that
could be used in field conditions, we generated monoclonal
antibodies to part purified recombinant IAPV empty capsids,
screening hybridomas in the first instance on purified VP2 protein.
Four strongly reactive antibodies, IAPVMAb8, IAPVMAb12,
IAPVMAb17 and IAPVMAb27 were selected for formal epitope
mapping using a library of 20 residue peptides overlapping by 10
made to the same IAPV VP2 sequence. Interestingly all four
antibodies reacted with the N-terminal extended tail of VP2
visualised in the available dicistrovirus structures [43,45]. Three
antibodies co-mapped to the extreme N-terminal sequence
TMPGDSQQES and one to an adjacent sequence ASST-
SENSVE (Figure 5A). As predicted by the mapping, IAPVMAbs
8, 12 and 17 competed when used as pairs in a twin site ELISA
assay with ORF2-5T-3C infected Sf9 cell extracts as the test
antigen but a combination of IAPVMAbs 12 and 27 were found to
allow a dose dependent detection of IAPV antigen in the test
lysates (Figure 5B). The antibody pairs had no reaction to Sf9 cells
that were not infected with an IAPV antigen expressing
baculovirus or bee lysate (not shown).
Discussion
We have assembled empty IAPV capsids in insect cells following
expression of IAPV structural proteins using a recombinant
baculovirus. The mature structural proteins were produced by
cleavage of a precursor protein, ORF2, by the authentic 3C-like
processing enzyme which was relocated from ORF1 and expressed
as a C-terminal fusion protein. Direct fusion of 3C to ORF2
showed only low levels of cleaved VP2 whereas lowering the
expression level of 3C through a translational control strategy
resulted in higher levels of mature capsid expression. This is
consistent with IAPV 3C activity exhibiting some cytotoxicity as
has been described for picornavirus 3C where moderation of 3C
activity through a mixture of translational control and 3C
mutation resulted in higher empty capsid yields [28]. In the case
of IAPV, a structure of the 3C-like enzyme is not available so
translational control through the use of a frameshift sequence
known to function in insect cells [47] was the sole option. It is likely
a similar strategy will work for other members of the Picornavir-
idae or Dicistroviridae where reduced 3C activity is required to
maximise capsid cleavage. Recombinant empty IAPV particles
with typical dicistrovirus appearance were observed by EM of
negatively stained sucrose gradient fractions and were immuno-
genic upon immunization. Monoclonal antibodies selected to VP2
were found to map exclusively to the extended N-terminal tail of
the molecule. Mapping the polyvalent response also showed this
region to be immunodominant, consistent with a poorly immu-
nogenic well folded jelly-roll capsid structure (not shown).
Notwithstanding a restricted repertoire in the immune response,
VP2 specific monoclonal antibody pairs were validated for ELISA
detection of IAPV antigen expressed in Spodoptera cells. The two
epitopes recognised are IAPV specific which suggests that a rapid
test for IAPV presence, such as a lateral flow device, would be
highly specific and suitable for use in the field. Such devices have
been described for diagnostic tests for other bee pathogens and
viruses [48,49]. The number of viruses infecting agriculturally
important insects such as the honeybee continues to grow and
mixed infections are common [7,10,11,15,50]. Methods to provide
the equivalent of a pure virus culture in the absence of the
requirements for infectious plaque assay could be useful to
generate highly specific protein based assays. Similarly, differences
in individual variants of one virus, such as the recently described
Varroa transmitted virulent form of DWV [16] could be assessed
for capsid function through such technology. Through such
studies, baculovirus expression of empty capsids following the co-
expression of the structural precursor and a suitably attenuated
Figure 3. Immunofluorescence of Sf9 cells infected for 2 days with constructs ORF2 and ORF2-5TFS-3C stained with anti IAPV VP2
and an anti-rabbit Alexa Fluor 488 conjugate. A – Sf9 mock infected control. B – Sf9 cells infected with construct ORF2 expressing ORF2 only. C
– Sf9 cells infected with construct ORF2-5TFS-3C expressing ORF2 fused with an attenuated 3C like protease. Occasional punctate staining is apparent
in C.
doi:10.1371/journal.pone.0105943.g003
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3C-like enzyme could contribute to better understanding the
honeybee-virus landscape at a molecular level.
Materials and Methods
Cell culture and virus growth
Sf9 cells (ATCC) were cultured in BioWhittaker Insect-Xpress
supplemented with 2% FCS, 100units/ml penicillin, 100 mg/ml
streptomycin and 2.5 mg/ml amphotericin B. Cells were grown at
28uC as monolayers or in suspension with agitation at 100 rpm.
Baculoviruses were generally amplified in monolayer cultures but
large scale infections for capsid isolation were done in suspension.
Virus stocks were titred using plaque assay on Sf9 monolayers.
Sequences and cloning
Sequences for IAPV were taken from the databases
(NC_009025) and synthesised de novo to include codon optimi-
sation for Spodoptera cells (Geneart). The transfer vector used for
all expression was based on pTriEx1.1 (EMD Bioscience) and
fragments encoding ORF2 and 3C were cloned downstream of the
P10 promoter via unique restriction sites introduced during gene
synthesis. Recombinant baculoviruses were constructed using
recombination with AcMNPV bacmid KO1629 in insect cells as
described [41]. Routine DNA procedures used standard protocols
or, when kits were used, those recommended by the vendor. All
vectors were confirmed by DNA sequencing prior to use for
expression.
Electrophoresis and Western blotting and Quantitation
Protein samples were separated on pre-cast 10% Tris.HCl SDS-
polyacrylamide gels (BioRad) and transferred to Immobilon-P
membranes (Millipore) using a semi-dry blotter. For 10 well gels
each sample loaded represented 56104 cells. Following transfer,
filters were blocked for one hour at room temperature using PBS
containing 0.1% v/v Tween-20 (PBS-T), 5% w/v milk powder.
Primary antibodies were used at a dilution of 1:5000 in PBS-T, 5%
w/v milk powder. Following several washes with PBS-T the
membranes were incubated for 1 hour with the appropriate HRP-
conjugates and the bound antibodies detected by BM chemilumi-
nescence (Roche). Bands were imaged using a Syngene G:Box
chemiluminescence imager and the image file processed for pixel
density by Genetools software (Syngene).
Figure 4. Analysis of empty IAPV capsids. A. Sucrose gradient analysis of Sf9 cell extracts infected with recombinant baculovirus ORF2-5TFS-3C.
Each fraction represents a 5% step from 30% to 60% sucrose w/v and is blotted with the IAPV anti VP2 serum. B. EM analysis of peak fractions from
the sucrose gradient shown in A. Empty capsids are indicated. A damaged particle is labelled D. Baculovirus nucleocapsids are labelled B. The bar is
100 nm.
doi:10.1371/journal.pone.0105943.g004
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Purification of empty capsids
Infected insect cell cultures (typically 1 L at ,106/ml) were
harvested at 3 days pi and lysed by resuspension in 1/20th of the
original volume of 1% Triton X-100 in PBS and held at 4uC for
30 minutes with occasional agitation. Unbroken cells and nuclei
were removed by centrifugation (4500 rpm, 30 min) and the
clarified lysate layered onto a 30% sucrose (w/v in PBS) cushion
and particles recovered by centrifugation at 100,000 g for 100
minutes. The gradient was discarded and the pellet resuspended in
1/10th tube volume of PBS containing 3500 units of benzonase.
After 30 min at room temperature the solution was clarified and
applied to a preformed sucrose gradient made up of seven steps of
Figure 5. Development of an IAPV capture ELISA. A. Pepscan of 4 monoclonal antibodies to IAPV VP2 on an overlapping peptide library. Filled
bars IAPVMAb8; stipple bars IAPVMAb12; striped bars IAPVMAb17; open bars IAPVMAb 27. The relationship between peptide identity and VP2
structure is shown. B. Twin site capture ELISA using capture MAbs 8 (triangles) and 27 (diamonds) as capture layer and probing with HRP-labelled
IAPV MAb12. The test sample was a lysate of Sf9 cell infected with the baculovirus expressing ORF-2-5TFS-3C.
doi:10.1371/journal.pone.0105943.g005
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5% from 30% to 60% w/v. The gradient was developed by
centrifugation at 100,000 g for 16 hrs and fractionated from the
top.
Electron microscopy
Samples were allowed to adhere to carbon coated formvar grids
for 5 min at room temperature followed by a brief water wash
(1 min) before staining with 1% uranyl acetate for 1 min. Excess
stain was removed by blotting and the grids examined on a Philips
CM20 operating at 80 kV.
Monoclonal antibody production
Monoclonal antibodies were produced under subcontract at
FERA, Sand Hutton, UK. Briefly, three mice were immunised
with 0.1 ml of recombinant IAPV empty capsids at 300 mg/ml
four times over an 8 week period. Following the last immunisation,
animals were sacrificed and splenocytes fused with myeloma cells
using polyethylene glycol 1500 as the fusion agent. Fusion cell
products were cultured in multi-well plates and cell culture
supernatants (CCS) harvested for screening on IAPV VP2 protein
at 12 days post fusion. Cell lines producing strongly reactive
antibody were cloned by limiting dilution and re-screened by
ELISA to produce pure hybridomas. Following scale –up, the
antibody in the CCS from selected cell lines was purified by
Protein G chromatography, concentrated to ,10 mgs/ml and
stored at 280 degrees centigrade. Immunisation and work with
vertebrate animals (mice) was performed under a UK Home
Office project license in accordance with the UK Animals
(Scientific Procedures) Act 1986 (UK Government 1986) using
the principles outlined in the Home Office guidance ‘Antibody
Production: Principles for Protocols of Minimal Severity’ (Home
Office 2000). The work adhered to the principles of the National
Centre for the Replacement, Refinement and Reduction of
Animals in Research see http://www.nc3rs.org.uk/page.
asp?id = 871.
Antibody labelling
To allow competition assays selected monoclonal antibodies
were labelled with horse radish peroxidase using the Lightning-
Link HRP Antibody Labeling Kit (Novus Biologicals).
ELISA assay
Immulon II ELISA plates (Nunc) were coated with antigen or
capture antibody at 10 mgs/ml in 200 mM sodium bicarbonate
overnight at 4uC. Plates were blocked with 1% bovine serum
albumin (BSA) in PBS containing 0.1% v/v Tween-20 (PBS-T)
and then washed with PBS-T. Subsequent layers were incubated
for 1 hour at 25uC and washed between layers with PBS-T. The
plate was developed with 50 ml per well of tetramethylbenzidine
(Europa Bioproducts UK) and the reaction stopped by the
addition of 50 ml of 0.1 M H2SO4. Absorbance was measured at
440 nm using a GENios plate reader (Tecan UK). Experiments
were performed in duplicate and the average plotted.
Epitope mapping
Overlapping peptides of 20 residues overlapping by 10 residues
to the VP2 sequence of IAPV and biotinylated at the N-terminus
were supplied by Think Peptides (UK). Peptides were dissolved in
DMSO at ,10 mgs/ml and added to streptavidin coated plates at
10 mg/ml. After 1 hr incubation to allow peptide capture the plate
was blocked and treated as described for ELISA.
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